TI
ALGS icon

Trexquant Investment’s Aligos Therapeutics ALGS Stock Holding History

Trexquant Investment’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.2K Buy
+12,339
New +$76.3K ﹤0.01% 1840
2025
Q2 		– Sell
-38,254
Closed -$316K – 1496
2025
Q1 		$316K Sell
38,254
-30,796
-45% -$675K ﹤0.01% 1378
2024
Q4 		$2.75M Buy
+69,050
New +$1.33M 0.03% 748

Other funds holding ALGS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Trexquant Investment's ALGS Position: Q2 2026 in Review

Trexquant Investment opened a new position in Aligos Therapeutics (ALGS) in Q2 2026: 12,339 shares worth $71.2K. The stake represents ﹤0.01% of the portfolio and ranks #1840 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in ALGS as recently as Q1 2025.

Trexquant Investment first reported a position in ALGS in Q4 2024 and has held it in 3 quarters since. The position peaked at $2.75M in Q4 2024. 31 funds tracked by Wall St. Rank hold ALGS as of Q2 2026.

  • Trexquant Investment held 12,339 shares of Aligos Therapeutics worth $71.2K as of Q2 2026.
  • Aligos Therapeutics was a new Trexquant Investment position in Q2 2026.
  • Aligos Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1840 holding.
  • Trexquant Investment first reported a position in Aligos Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Trexquant Investment's Aligos Therapeutics position peaked at $2.75M in Q4 2024.
  • 31 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.